Last updated: 2026-10-13 13:46:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Journey Medical Corporation (DERM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5,77, with a market capitalisation of $178,10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4,31 to $9,56. This page covers its latest market performance, valuation, price trends and company information.
$178,10M | |
$5,91 | |
$38,75 | |
$1,02 | |
$5,91 | |
45,16K | |
186,61K | |
-- | |
$9,56 | |
$4,31 | |
-- | |
-- |
Journey Medical Corporation (DERM) is currently trading at $5,77 as of 2026-10-13 13:45:00, down 2,44% ($0,14) from the previous close of $5,91
During today's regular trading session, DERM has traded between $1,02 and $38,75, with a trading volume of 45,16K shares. The current price is near the lower end of today's range.
Over the past seven days, Journey Medical Corporation (DERM) moved from $6,61 to $5,77, representing a decline of 12,77% ($0,84).
The stock traded between $5,77 and $6,88 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 185,51 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 27,8%
DERM is currently trading at $5,77, placing it 27,8% of the way from its 52-week low of $4,31 to its 52-week high of $9,56. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 58 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Journey Medical Corporation (DERM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.